Revista Colombiana de Bioetica, an esteemed publication under the auspices of UNIV EL BOSQUE, serves as a pivotal platform in the interdisciplinary field of bioethics, offering insights and scholarly discourse relevant to researchers, professionals, and students alike. With an ISSN of 1900-6896 and an E-ISSN of 2590-9452, this open access journal, available since 2010, champions the democratization of knowledge, ensuring that vital research is accessible to all. Nestled in Bogotá, Colombia, the journal's commitment to ethical inquiry and critical thinking in biomedical and health-related disciplines positions it as a crucial resource for those keen on exploring the intersections of ethics, law, philosophy, and health sciences. By facilitating the exchange of innovative ideas and research, the Revista Colombiana de Bioetica aspires to inspire informed dialogue and foster ethical practices within the scientific community and beyond.

The Journal of Bioethical Inquiry, published by Springer, is a prominent academic journal in the fields of bioethics, health policy, and social sciences. Established in 2004 and running through 2024, it is recognized for providing a critical platform for the exploration of ethical issues arising in the contexts of healthcare and policy making. With an ISSN of 1176-7529 and an E-ISSN of 1872-4353, this esteemed journal holds a Q2 quartile ranking in both Health Policy and Health (Social Science) categories, indicating its significant impact and contributions to the field. It boasts impressive Scopus rankings, with a standing of #70 out of 371 in Social Sciences _ Health (Social Science) and #68 out of 310 in Medicine _ Health Policy, representing its relevance and authority in these domains. Although it does not currently offer open access options, the Journal of Bioethical Inquiry remains a vital resource for researchers, practitioners, and students eager to engage with the complexities of bioethical challenges and to advance the discourse on health policies.

Acta Bioethica is a pivotal open access journal published by the Universidad de Chile's Centro Interdisciplinario de Estudios Bioética, dedicated to the multidisciplinary exploration of bioethical issues in health policy and social sciences. Since its inception in 2000, the journal has fostered dialogue among researchers, professionals, and students, addressing the complexities of ethical practices in diverse health contexts. With an impressive commitment to accessibility, Acta Bioethica has become a vital resource for those engaged in understanding the ethics of healthcare in Latin America and beyond. Although currently ranked in the lower quartiles of Scopus in both health policy and social sciences, the journal is steadily gaining recognition for its unique contributions to bioethics. The journal accepts contributions in both English and Spanish, ensuring a wider reach and impact in the academic community. Located in Santiago, Chile, and active from 2007 to 2024, Acta Bioethica continues to be an essential platform for advancing research and discussions in the ever-evolving field of bioethics.

American Journal of Bioethics (ISSN: 1526-5161, E-ISSN: 1536-0075) is a premier publication in the field of bioethics, published by Routledge Journals, Taylor & Francis Ltd, renowned for its commitment to advancing scholarly discourse. Established in 2001, the journal is positioned at the forefront of ethical discussions in healthcare, evidenced by its impressive Q1 rankings in both Health Policy and Issues, Ethics, and Legal Aspects in 2023. With an emphasis on high-impact research, it holds a prestigious Scopus Rank of #1/46 in Nursing and #9/310 in Medicine, showcasing its significance in shaping bioethical considerations. Though not classified as an open access journal, its contents are integral for researchers, practitioners, and students engaged in ethical policymaking and advocacy. By addressing contemporary ethical dilemmas and legal nuances within healthcare, the American Journal of Bioethics serves as an essential resource for fostering an informed dialogue and influencing policy development across the globe.

Ethik in der Medizin, published by Springer, is a distinguished journal focusing on the interdisciplinary aspects of ethics in medicine, healthcare policy, and philosophical inquiries related to these domains. With an ISSN of 0935-7335 and an E-ISSN of 1437-1618, this journal serves as a platform for innovative research and discussion from Germany and beyond. The journal boasts an impact in several prestigious categories including Q3 in Health Policy and Q2 in Philosophy as of 2023, reflecting its significant contribution to the discourse on ethical implications in health and medicine. Although not currently Open Access, Ethik in der Medizin provides valuable insights for researchers, professionals, and students interested in the complexities of health ethics and policies, positioning itself as an essential resource in academia. The journal is undergoing important developments, as it converges from 2001 with a publishing timeline extending to 2024, ensuring continued relevance in a rapidly evolving field.

New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body, published by Taylor & Francis Ltd, serves as a pivotal platform for scholarly discourse at the intersection of biotechnology, health policy, and bioethics. With an ISSN of 2050-2877 and E-ISSN 2050-2885, this journal has been contributing to the academic community since its establishment in 2012 and is set to continue through 2024. It holds notable rankings in prestigious fields, including Q4 in Genetics (clinical), Q3 in Health Policy, Q2 in Issues, Ethics and Legal Aspects, and Q3 in Reproductive Medicine as per 2023 quartile indicators. Although no open access model is available, the journal remains an essential resource for those interested in the ethical implications of biotechnological advancements. Its focus on the ethical, legal, and social dimensions of biotechnology is particularly relevant in today's rapidly evolving scientific landscape, making it invaluable for researchers, professionals, and students keen to explore the complexities surrounding the biotechnology and the human condition.

The HASTINGS CENTER REPORT, published by WILEY, is a leading journal in the fields of bioethics, health policy, and the philosophical underpinnings of healthcare. Established in 1971, this influential publication provides a critical platform for the discussion of ethical issues in health, medicine, and biotechnology, highlighting the intersection between ethical theory and practical health challenges. The journal achieves remarkable academic stature, achieving Q1 rankings in both Issues, Ethics and Legal Aspects and Philosophy, alongside Q2 standings in Health Policy and Health (social science) categories, reflecting its broad interdisciplinary impact. With its wide readership and rigorous peer-review process, the HASTINGS CENTER REPORT serves as an essential resource for researchers, practitioners, and students dedicated to advancing ethical perspectives in health-related discourse. While the journal operates under traditional access options, its contributions resonate deeply within the academic community, fostering informed dialogue on pressing ethical dilemmas and policy considerations in a rapidly evolving healthcare landscape.

The European Journal of Health Law, published by Brill, stands as a pivotal resource for scholars and practitioners at the intersection of health policy and law since its inception in 1994. This esteemed journal, with an ISSN of 0929-0273 and an E-ISSN of 1571-8093, delves into pressing issues affecting health law across Europe and beyond, providing a platform for rigorous scholarly discourse. It is categorized in the Q4 quartile for Health Policy and Q3 for Law, highlighting its crucial role in advancing knowledge in these fields. While the journal is not an open-access publication, its content remains vital for researchers, students, and professionals seeking to navigate the complexities of health law amidst evolving legal frameworks. With an increasing focus on interdisciplinary studies, the journal aims to foster a deeper understanding of legal principles and their application to health care governance, policy-making, and ethical considerations, making it an indispensable reference for those committed to enhancing health law practice and scholarship.

Revista de Direito Sanitario-Journal of Health Law is a prominent academic publication in the field of health law, published by the esteemed University of São Paulo (UNIV SAO PAULO), Brazil. With a focus on the intersection of law and public health, this Open Access journal has been disseminating vital research since its inception in 2013, allowing for wide accessibility and engagement from scholars and practitioners alike. The journal serves as a critical forum for advancing discussions on health-related legal issues, policy implications, and regulatory frameworks. While currently positioned in the fourth quartile in health (social science) and medicine (miscellaneous), and the third quartile in law, its acceptance and visibility continue to grow within the global academic community. The insights shared in this journal are invaluable for those striving to enhance legal practice and health policy, making it an indispensable resource for researchers, professionals, and students committed to the advancement of health law and its implications in society.

The KENNEDY INSTITUTE OF ETHICS JOURNAL, published by the prestigious Johns Hopkins University Press, stands as a leading periodical in the realm of ethics, particularly emphasizing the intersection of health policy, social sciences, history, and philosophy of science. With an ISSN of 1054-6863 and an E-ISSN of 1086-3249, this journal has been a cornerstone of ethical discourse since its inception in 1991. Renowned for its rigorous peer-review process, the journal boasts impressive rankings, including Q1 in History and Philosophy of Science and Q2 in Health (Social Science) for 2023. Researchers, professionals, and students alike will find this journal invaluable for navigating complex ethical issues, providing a platform for innovative research and discourse. Although currently not offering Open Access, its contributions to the fields of ethics and legal aspects of health are profound, making it an essential resource for those engaged in these critical discussions.